Impact of ultrasound to increase medication absorption on skin health and quality of life of acne patients

Impact of sonophoresis using a seboregulating ampoule on selected skin parameters and the quality of life acne patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN98261720

Enrollment

Registered

2020-01-17

Start date

2020-02-04

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris Skin and Connective Tissue Diseases Acne vulgaris

Interventions

Five sessions of sonophoresis with a seboregulating ampoule (Group A) or placebo (Group B) will be made over seven days. After this time skin parameters will be measured (7 and 14 days after finishing

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Female aged 19-23 years 2. Acne vulgaris

Exclusion criteria

Exclusion criteria: 1. Severe acne 2. Pregnancy, lactation 3. Active inflammation of the skin 4. Bacterial, viral, allergic and fungal relapsing skin diseases 5. Disturbed skin continuity 6. Fresh surgical procedures in the treatment area 7. Active Herpes 8. Treatment with isotretinoin 9. Reduced immunity 10. Cancer/tumour 11. Heart problems (peacemaker) 12. Implants (metal, silicone, saline) 13. Skin allegry 14. Active tuberculosis

Design outcomes

Primary

Measure	Time frame
Skin sebum content measured using the Sebumeter? at baseline, one-week and two-weeks after finishing the treatments	—

Secondary

Measure	Time frame
1. Skin hydration measured using a Corneometer? at baseline, one-week and two-weeks after finishing the treatments 2. Transepidermal pH measured using Skin-pH-Meter at baseline, one-week and two-weeks after finishing the treatments 3. General quality of life of patients with acne vulgaris measured using the Hellgren and Vincent scale and also Skindex-29 and DLQI questionnaries at baseline and two weeks after finishing the treatments	—

Measure

Time frame

1. Skin hydration measured using a Corneometer? at baseline, one-week and two-weeks after finishing the treatments 2. Transepidermal pH measured using Skin-pH-Meter at baseline, one-week and two-weeks after finishing the treatments 3. General quality of life of patients with acne vulgaris measured using the Hellgren and Vincent scale and also Skindex-29 and DLQI questionnaries at baseline and two weeks after finishing the treatments

—

Countries

Poland

Contacts

Public ContactKarolina Chilicka

karolina.chilicka@poczta.onet.pl665439443

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026